Travere Therapeutics Stock (TVTX)

Track Travere Therapeutics stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.

$47.17

▲ +32.42 (+211.34%) past year

Live · Updated May 28, 5:22 PM

Market Cap

$4.12B

P/E Ratio

—

1Y Return

+211.34%

EPS (TTM)

-$0.53

Read the latest TheStreet Pro articles mentioning Travere Therapeutics, including market roundups, portfolio updates, trade ideas, and investing analysis.

Articles

3 articles

market-commentary I’m Tightly Trading Two Stocks While Protecting Gains
James "Rev Shark" DePorreMay 27, 2026
TVTX AIRJ GEV
trade-ideas Two Biotechs to Play in Uncertain Times
Bret JensenJan 16, 2026
TVTX C BAC
trade-ideas As Everyone Watches the Fed, I'm Watching These 2 Biotechs
Bret JensenSep 12, 2025
TVTX ORCL PSKY

Daily Diary Mentions

0 mentions

No diary mentions for TVTX yet.